new obesity drug, Meridia

April 2001

Knoll is now shipping their new obesity drug, Meridia.

Meridia (sibutramine) curbs appetite by inhibiting the reuptake of norepinephrine and serotonin...and, to a lesser extent, dopamine.

This helps patients stick to a low-calorie diet...and lose about 5% to 10% of their body weight.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

hear a lot more about "QT interval drugs"
Obesity & Weight Loss new obesity drug, Meridia
Acetaminophen underestimate acetaminophen's ability to damage the liver
Infectious Diseases Tequin (gatifloxacin), a new broad-spectrum quinolone
Infectious Diseases new HIV protease inhibitor called Kaletra
Prozac Weekly, a new ONCE-A-WEEK fluoxetine capsule to prevent a recurrence of depression
Wellbutrin SR (bupropion) for adults with ADHD
more aggressive treatment of depression
Gastroenterology new proton pump inhibitor called Nexium
Gastroenterology rifabutin (Mycobutin) for resistant cases of H. pylori
Testosterone new testosterone patch called Androderm
Women's Health new warning on Monistat packages about an interaction with warfarin
Women's Health promising new approach to preserve fertility in women undergoing chemotherapy
Cardiology Plavix (clopidogrel) and ASA is more effective than ASA alone for treating unstable angina
Cardiology whether patients with chronic heart failure should take ASA
if some dietary supplements can transmit the human form of mad cow disease